75 results
Page 2 of 4
S-8
EX-99.1
1y7 68by01q
31 Aug 22
Registration of securities for employees
4:32pm
8-K
EX-99.1
fcl5e3
27 Jun 22
Entry into a Material Definitive Agreement
7:31pm
8-K
EX-99.1
pdam72il
16 Jun 22
Other Events
7:00am
POS AM
tn6t32o9bpjkk9dmo
28 Feb 22
Prospectus update (post-effective amendment)
5:46pm
POSASR
8i1cf
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
8-K
EX-99.1
ys0rgozy5xda 8lx
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
EX-99.1
4c68va90fro
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
noy3edhw9u dw5xcmob
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
r5gba2jhr eui65
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
s89xyx4l2xgf8ys wz
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
S-8
EX-99.1
nacqyetsbyg4pqaruo3y
9 Aug 21
Registration of securities for employees
12:00am
8-K
EX-99.2
vb2j9bq7
19 May 21
Regulation FD Disclosure
5:00pm